The Procurement of a supply of Whole Blood and Apheresis Platelets for Research
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 621991 Blood and Organ Banks
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring a supply of whole blood and apheresis platelets for research supporting the Pathogen Reduction Technology Program (CBER/OBRR/IOD/PRT), with an estimated award date of December 1, 2026. No set-aside applies to this requirement.
The estimated award value ranges from $10,000 to $25,000. For additional information, contact the FDA acquisition mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
The Procurement of a supply of Whole Blood and Apheresis Platelets for Research for the Pathogen Reduction Technology Program (CBER/OBRR/IOD/PRT)
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast